logo
搜索
菜单

PK的搜索结果

当前1/3页
排序: 本周浏览数
A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants 10.3791/3807-v 14:56 min
A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain 10.3791/3788-v 11:29 min
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model 10.3791/3716-v
Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
15.16: Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions 01:15 min
15.16: Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
15.15: Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model 01:14 min
15.15: Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems 01:24 min
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect 01:26 min
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
The Analysis of Purkinje Cell Dendritic Morphology in Organotypic Slice Cultures 10.3791/3637-v 07:59 min
The Analysis of Purkinje Cell Dendritic Morphology in Organotypic Slice Cultures
Monitoring Kinase and Phosphatase Activities Through the Cell Cycle by Ratiometric FRET 10.3791/3410-v 13:38 min
Monitoring Kinase and Phosphatase Activities Through the Cell Cycle by Ratiometric FRET
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy 10.3791/3400-v 09:13 min
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
7.23: Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance 01:07 min
7.23: Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Spheroid Assay to Measure TGF-β-induced Invasion 10.3791/3337-v 09:18 min
Spheroid Assay to Measure TGF-β-induced Invasion
6.7: Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa 01:22 min
6.7: Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
5.14: Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs 01:21 min
5.14: Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
3.25: Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH 01:21 min
3.25: Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
28.25: Inborn Errors of Metabolism 01:20 min
28.25: Inborn Errors of Metabolism
Live-imaging of PKC Translocation in Sf9 Cells and in Aplysia Sensory Neurons 10.3791/2516-v 09:54 min
Live-imaging of PKC Translocation in Sf9 Cells and in Aplysia Sensory Neurons
20.2: Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors 01:28 min
20.2: Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
3.13: Buffers: Buffer Capacity 01:09 min
3.13: Buffers: Buffer Capacity
3.6: Solution Composition During Acid/Base Titrations 01:17 min
3.6: Solution Composition During Acid/Base Titrations
返回顶部